Intermediateclinical correlationsArticle

Celiac Disease: How Gluten Triggers Villous Destruction

Learning objectives

  • Explain why gluten peptides resist complete digestion.
  • Describe tissue transglutaminase's role in deamidating gliadin.
  • Explain the HLA-DQ2/DQ8 genetic requirement.
  • Describe villous atrophy and crypt hyperplasia mechanistically.
  • Explain how villous loss causes malabsorption and its consequences.

Gluten: a protein built to resist digestion

Gluten is a composite of storage proteins (gliadins and glutenins) found in wheat, barley, and rye. What makes gluten unusual is its amino acid composition: it is exceptionally rich in proline and glutamine. Human digestive enzymes — pepsin, trypsin, pancreatic proteases — cleave poorly at proline residues, so gluten digestion leaves behind long, intact peptide fragments, including a notorious 33-amino-acid gliadin fragment that survives the stomach and small intestine essentially whole. In most people these fragments pass harmlessly. In celiac disease, they become the trigger for one of the most precisely mapped autoimmune cascades in medicine.

Tissue transglutaminase: the enzyme that marks gluten for attack

The pivotal step occurs when gliadin fragments cross the intestinal epithelium — more easily when the barrier is slightly leaky — and encounter tissue transglutaminase (tTG), an enzyme abundant in the tissue beneath the epithelium. tTG chemically modifies gliadin through deamidation, converting specific glutamine residues into glutamate. This seemingly small change gives the peptide a negative charge — and that negative charge is the key that fits the lock of the immune system's antigen-presenting molecules. Ironically, tTG itself then becomes a target of the autoimmune response, which is why antibodies against tTG are the hallmark marker of the disease.

The genetic lock: HLA-DQ2 and HLA-DQ8

Deamidated gliadin binds with high affinity to two specific variants of the HLA class II antigen-presenting molecules: HLA-DQ2 and HLA-DQ8. Nearly everyone with celiac disease carries one of these variants — they are necessary but not sufficient, since about a third of the general population carries them without developing disease. When DQ2 or DQ8 presents the modified gliadin to CD4+ helper T cells in the gut-associated lymphoid tissue, those T cells recognize it as a threat and launch a coordinated immune response: releasing inflammatory cytokines (especially interferon-gamma), activating killer intraepithelial lymphocytes, and driving B cells to produce antibodies against both gliadin and tTG.

Villous atrophy: the battlefield aftermath

The immune assault's casualties are the intestinal villi — the millions of finger-like projections that multiply the small intestine's absorptive surface area by orders of magnitude. Activated intraepithelial lymphocytes destroy the epithelial cells at the villus tips faster than stem cells in the crypts can replace them, while crypt cells proliferate frantically in compensation (crypt hyperplasia). The net result is villous atrophy: villi shrink, flatten, and eventually disappear, leaving a smooth, scarred mucosal surface. The intestine's absorptive surface can collapse from the area of a tennis court to a fraction of that — and with the surface goes the machinery of absorption: the brush-border enzymes and transporters that live on villus cells.

From flattened villi to whole-body consequences

Malabsorption in celiac disease is a direct mechanical consequence of lost surface area. Fat malabsorption produces bulky, greasy stools; iron and folate malabsorption cause anemia; calcium and vitamin D malabsorption weaken bone; and protein-energy malnutrition can stunt growth in children. The damage also extends beyond the gut: the same immune activation is associated with dermatitis herpetiformis (an intensely itchy blistering skin rash where related antibodies deposit), neurological symptoms, and other autoimmune conditions. Because the entire cascade depends on continued gluten exposure, the villi can regenerate once the trigger is removed — the mucosa is remarkably capable of rebuilding its architecture when the immune assault stops.

Educational use only

This content is educational only and is not medical advice. It explains how body mechanisms work and does not replace professional medical evaluation.

Key points

  • Gluten's proline-rich gliadin fragments resist digestive enzymes and survive to the small intestine intact.
  • Tissue transglutaminase deamidates gliadin, giving it the negative charge needed to bind HLA-DQ2/DQ8.
  • HLA-DQ2 or DQ8 is present in nearly all cases — necessary but not sufficient for disease.
  • CD4+ T-cell activation drives intraepithelial lymphocyte killing of villus tip cells, causing villous atrophy with crypt hyperplasia.
  • Flattened villi lose absorptive surface, brush-border enzymes, and transporters, producing multi-nutrient malabsorption.
  • The mucosa can regenerate its villous architecture once gluten exposure stops.

Common misconceptions

✗ Myth: Celiac disease is a wheat allergy.

✓ Truth: Wheat allergy is an IgE-mediated immediate hypersensitivity; celiac disease is a T-cell-driven autoimmune attack on the intestinal mucosa itself, with tissue destruction that allergies do not cause.

✗ Myth: Gluten sensitivity and celiac disease are the same thing.

✓ Truth: Celiac disease has a defined autoimmune mechanism — tTG deamidation, HLA-DQ2/DQ8 presentation, villous atrophy — with measurable tissue damage, unlike non-celiac gluten sensitivity, which lacks these features.

✗ Myth: If you carry HLA-DQ2 you will definitely develop celiac disease.

✓ Truth: About a third of the population carries DQ2 or DQ8, but only a small fraction develops disease — the genes are necessary but far from sufficient; additional triggers are required.

✗ Myth: Celiac disease only affects the gut.

✓ Truth: The same immune cascade is linked to dermatitis herpetiformis, anemia, bone loss, neurological symptoms, and other autoimmune conditions — it is a systemic immune disorder triggered in the gut.

Frequently asked questions

Why can't the body just digest gluten completely?

Gluten is unusually rich in proline, and human digestive proteases cleave poorly at proline residues. Long gliadin fragments — including a 33-amino-acid peptide — survive stomach and pancreatic digestion essentially intact.

What does tissue transglutaminase do in celiac disease?

tTG deamidates gliadin peptides, converting glutamine to glutamate and giving them a negative charge. This modification lets them bind tightly to HLA-DQ2/DQ8, which presents them to T cells and ignites the autoimmune response.

Why do the intestinal villi flatten in celiac disease?

Activated intraepithelial lymphocytes destroy villus-tip epithelial cells faster than crypt stem cells can replace them. The villi shrink and flatten (villous atrophy) while crypts over-proliferate in compensation (crypt hyperplasia).

How does villous atrophy cause anemia and bone loss?

Absorptive surface, brush-border enzymes, and transporters are lost with the villi. Iron, folate, calcium, and vitamin D absorption all fall, producing anemia and impaired bone mineralization.

Can the intestine recover from celiac damage?

Yes — the mucosa regenerates remarkably well. Because the entire immune cascade depends on ongoing gluten exposure, villi regrow and absorptive function returns once the trigger is removed.